Return On Equity ratio Analysis of Procter & Gamble Health Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY ROE
Period Ending - Dec-24
Excellent ROE
58.21
Period Ending - Dec-23
Very Good ROE
42.99
Growth
35.40 %
Trailing Twelve Months ROE
Period Ending - Dec-24
Excellent ROE
54.44
Most recent Quarter ROE
Period Ending - Jun-25
Very Good ROE
12.32
ROE Analysis of Procter & Gamble Health Ltd.
| ROE Ratio of Procter & Gamble Health Ltd. with value of 54.44 means its generates profits efficiently by using its Shareholders Fund. |
| ROE Ratio of PGHL rose handsomely by 35.40 % this year. |
| ROE Ratio with value of 58.21 was highest in Year Dec-24 in last Five Years. |
| ROE Ratio with value of 25.12 was lowest in Year Dec-20 in last Five Years. |
| Latest ROE Ratio with value of 58.21 is Greater than Average ROE of 37.62 in last five years. |
Other ROE Related Info of PGHL that may interest you.
Procter & Gamble Health Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| PGHL | 6166.50 | 6176.50 | 0.162 % | Drugs & Pharma |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..
ROE Related Ratios
| ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
| Good Profitability | Screener |
FY - Historical Return On Equity of Procter & Gamble Health Ltd.
| Period | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|---|
| ROE | 58.21 | 42.99 | 30.56 | 31.23 | 25.12 | 28.03 | 54.46 |
| Change | 35.40 % | 40.67 % | -2.14 % | 24.30 % | -10.38 % | -48.52 % | 325.22 % |
| Price | 5238.05 | 4947.75 | 3953.00 | 5338.40 | 6817.50 | 4366.70 | 3078.70 |
| Price Change | 5.87 % | 25.16 % | -25.95 % | -21.70 % | 56.12 % | 41.84 % | 138.71 % |